Use of Preoperative FDG PET/CT and Survival of Patients with Resectable Non–Small Cell Lung Cancer

WM Chen, M Chen, JG Hsu, TS Lee, BC Shia, SY Wu - Radiology, 2022 - pubs.rsna.org
… with squamous cell carcinoma, adenocarcinoma, or others (… PET/CT group than in the
non–preoperative FDG PET/CT group. All covariates had absolute standardized mean difference

[HTML][HTML] Recent and current advances in FDG-PET imaging within the field of clinical oncology in NSCLC: a review of the literature

K Kaseda - Diagnostics, 2020 - mdpi.com
… histological subtypes of lung adenocarcinoma, and several … and survival in patients with
lung adenocarcinoma [2,24,25]. … fully the immunometabolic differences between NSCLC …

Consistency and prognostic value of preoperative staging and postoperative pathological staging using18F-FDG PET/MRI in patients with non-small cell lung cancer

A Kajiyama, K Ito, H Watanabe, S Mizumura… - Annals of Nuclear …, 2022 - Springer
… A representative image showing the difference in N staging between PET/MRI and CT … lung
adenocarcinoma. Park et al. reported that the pathologic tumor size of lung adenocarcinoma

[HTML][HTML] Differences among [18F]FDG PET-derived parameters in lung cancer produced by three software packages

A Bos-Liedke, P Cegla, K Matuszewski, E Konstanty… - Scientific Reports, 2021 - nature.com
… In the present study, we examined the differences among [ 18 F]FDG PET metabolic and …
Moreover, the tumour differentiation of adenocarcinoma as well as the size of all NSCLCs …

Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer

J Zhang, X Zhao, Y Zhao, J Zhang, Z Zhang… - European journal of …, 2020 - Springer
PET/CT radiomics-based model to predict EGFR mutation status in patients with lung
adenocarcinoma… , finding that the PET radiomic features could characterize the differences in …

Relationship of EGFR mutation to glucose metabolic activity and asphericity of metabolic tumor volume in lung adenocarcinoma

W Whi, S Ha, S Bae, H Choi, JC Paeng… - Nuclear medicine and …, 2020 - Springer
… in lung adenocarcinoma (ADC) and is more often observed in Asian population. In lung ADC,
some radiomics parameters of FDG PET … no significant difference in any of the tested PET

[HTML][HTML] Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT

Y Li, W Mu, Y Li, X Song, Y Huang, L Jiang - EJNMMI research, 2021 - Springer
… In the present study, although there were significant differences in SUVmax of lung tumor
and tumor attachment to the pleura between MPE and BPE, these two parameters were not …

[HTML][HTML] Diagnostic performance of zero-TE lung MR imaging in FDG PET/MRI for pulmonary malignancies

F Zeng, M Nogami, YR Ueno, T Kanda, K Sofue… - European …, 2020 - Springer
… (n = 255) and those showing apparent differences in lung findings between PET/MRI and
CT … A case showing lung adenocarcinoma in a 61-year-old man after surgery for pharyngeal …

Efficacy evaluation of neoadjuvant immunotherapy plus chemotherapy for non-small-cell lung cancer: comparison of PET/CT with postoperative pathology

Y Cheng, Z Chen, J Huang, D Shao - European Radiology, 2023 - Springer
… was diagnosed with invasive adenocarcinoma in an acinar … The difference between the
PET/CT efficacy evaluation and … inflammatory response after lung cancer immunotherapy …

Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F] FDG PET using volume-based parameters in non-small cell lung …

M Ishimura, T Norikane, K Mitamura… - Nuclear Medicine …, 2022 - journals.lww.com
… , adenocarcinoma is the most common subtype of lungPET parameters and EGFR mutation
status, the statistical analysis was done with the Mann–Whitney U test. Differences in PET